共 42 条
Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians
被引:13
|作者:
Daniel, Hilary
[1
]
Bornstein, Sue S.
[2
]
Carney, Jan K.
Cooney, Thomas G.
Engel, Lee S.
Gantzer, Heather E.
Henry, Tracey L.
Lenchus, Joshua D.
McCandless, Bridget M.
Southworth, Molly B.
Syed, Fatima
Quinton, Jacob
Wallace, Mary Anderson
机构:
[1] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA
[2] Texas Med Home Initiat, Dallas, TX USA
关键词:
D O I:
10.7326/M19-0035
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.
引用
收藏
页码:823 / +
页数:7
相关论文